<乌鸦传媒視頻 class="page_title">Expert Q&A
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
<乌鸦传媒視頻>
.jpg)
Christos S. Mantzoros, MD, DSc, PhD, professor of medicine at Harvard Medical School and Boston University, answers our questions about changes in the way we approach steatotic liver disease, formerly known as fatty liver disease.